Due to a failure to operate properly at extremely high glucose readings, Johnson & Johnson is recalling and replacing approximately two million meters used to measure blood glucose levels in diabetics.
Here in the United States, about 90,000 OneTouch Verio IQ meters were sold. The units have failed to provide a warning of dangerously high blood sugar as well as high glucose readings of 1024 mg/dl and above and will shut off, which can delay proper treatment.
The company is also recalling about 4,000 of the OneTouch Verio Pro meters found in the Middle East, Europe and the Asia/Pacific Region, as well as 670,000 of the meters in Europe.
No patient injuries have been reported in the U.S. due to the malfunction. The company stated that patients should continue using the Verio IQ model until replacements arrived.